ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FX04 | BioTech | Ipilimumab - 50mg/10ml | 7938/388 | 80114/1 | YERVOY | 50mg/10ml | 1x10ml | Injectable solution | Infusion | Pacific pharma | Bristol-Myers Squibb Holdings Pharma Ltd Liability Company Manati | USA | L.L | 2.44 | E2 | Bristol-Myers Squibb Company | USA | 2/5/2024 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FX04 | BioTech | Ipilimumab - 50mg/10ml | 7938 | 80114/1 | YERVOY | 50mg/10ml | 1x10ml | Injectable solution | Infusion | Pacific pharma | Bristol-Myers Squibb Holdings Pharma Ltd Liability Company Manati | USA | 332,262,937 L.L | 2.44 | E2 | Bristol-Myers Squibb Company | USA | 2/5/2024 | 0 |